Deya Corzo
Keine laufenden Positionen mehr
Karriereverlauf von Deya Corzo
Ehemalige bekannte Positionen von Deya Corzo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SIGILON THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 | 01.08.2021 |
Sojournix, Inc.
 Sojournix, Inc. BiotechnologyHealth Technology Sojournix, Inc. operates in the healthcare industry focusing on biotechnology business. It develops medicines for women’s health and endocrine disorders. The company was founded by Scott L. Rakestraw and Daniel Grau in 2016 and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 | 01.01.2018 |
| UNIQURE N.V. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 | 01.01.2017 |
| CELGENE | Corporate Officer/Principal | 01.01.2012 | 01.01.2014 |
Ausbildung von Deya Corzo
| Universidad Industrial de Santander | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Niederlande | 2 |
| Kolumbien | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| UNIQURE N.V. | Health Technology |
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Sojournix, Inc.
Sojournix, Inc. BiotechnologyHealth Technology Sojournix, Inc. operates in the healthcare industry focusing on biotechnology business. It develops medicines for women’s health and endocrine disorders. The company was founded by Scott L. Rakestraw and Daniel Grau in 2016 and is headquartered in Waltham, MA. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Börse
- Insiders
- Deya Corzo
- Erfahrung
